Korean J Pain.  2020 Oct;33(4):326-334. 10.3344/kjp.2020.33.4.326.

Effect of intraperitoneally administered propentofylline in a rat model of postoperative pain

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul, Korea
  • 2Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea
  • 3Department of Plastic Surgery, National Police Hospital, Seoul, Korea

Abstract

Background
In this study, we sought to evaluate whether systemic propentofylline (PPF) has antiallodynic effects in a rat model of postoperative pain, and to assess the mechanism involved.
Methods
After plantar incision, rats were intraperitoneally injected with various doses of PPF to evaluate its antiallodynic effect. To investigate the involved mechanism, rats were intraperitoneally injected with yohimbine, dexmedetomidine, prazosin, naloxone, atropine or mecamylamine, following the incision of the rat hind paws, and then PPF was administered intraperitoneally. The mechanical withdrawal threshold (MWT) was evaluated using von Frey filaments at various time points and serum levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were measured to determine the inflammatory response level.
Results
MWT was significantly increased after intraperitoneal injection of 30 mg/ kg of PPF when compared with the control group. Injection of PPF and yohimbine, atropine or mecamylamine showed significant decreases in the MWT, while injection of PPF and dexmedetomidine showed a significant increase. Systemic administration of PPF inhibited the post-incisional increase in serum level of TNF-α and IL-1β.
Conclusions
Systemic administration of PPF following surgery presented antiallodynic effects in a rat model of postoperative pain. The antiallodynic effects against mechanical allodynia could be mediated by α-adrenergic and cholinergic receptors.

Keyword

Acute pain; Animals; Hyperalgesia; Injections; Intraperitoneal; Pain; Pain Management; Pain; Postoperative; Propentofylline; Rats

Figure

  • Fig. 1 Antiallodynic effect of post-incisional-administered propentofylline (PPF). BL: baseline, AI: after incision. *P < 0.05 compared with the control group.

  • Fig. 2 Antiallodynic mechanisms of propentofylline (PPF) with (A) dexmedetomidine, yohimbine or prazosin and (B) naloxone, mecamylamine or atropine. BL: baseline, AI: after incision. *P < 0.05 compared with the PPF 30 mg/kg group.

  • Fig. 3 Effects of propentofylline (PPF) on Rotarod testing. BL: baseline.

  • Fig. 4 Effect of propentofylline (PPF) on the plasma concentration of (A) tumor necrosis factor (TNF)-α, (B) interleukin (IL)-1β (C) and IL-6. *P < 0.05 compared with control group.

  • Fig. 5 Antiallodynic effect of propentofylline (PPF) 30 mg/kg compared with ketorolac 30 mg/kg and control group. BL: baseline, AI: after incision. *P < 0.05 compared with control group, †P < 0.05 compared with PPF 30 mg/kg group.

  • Fig. 6 Area under curve for mechanical withdrawal threshold for the comparison of propentofylline (PPF) 30 mg/kg, ketorolac 30 mg/kg and control group. *P < 0.05 compared with control group.


Reference

1. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. 2003; Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 97:534–40. DOI: 10.1213/01.ANE.0000068822.10113.9E. PMID: 12873949.
Article
2. Gan TJ, Habib AS, Miller TE, White W, Apfelbaum JL. 2014; Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 30:149–60. DOI: 10.1185/03007995.2013.860019. PMID: 24237004.
Article
3. Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, et al. 2016; Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 17:131–57. DOI: 10.1016/j.jpain.2015.12.008. PMID: 26827847.
Article
4. Sweitzer S, De Leo J. 2011; Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain. Handb Exp Pharmacol. (200):235–50. DOI: 10.1007/978-3-642-13443-2_8. PMID: 20859798.
Article
5. Raghavendra V, Tanga F, Rutkowski MD, DeLeo JA. 2003; Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain. 104:655–64. DOI: 10.1016/S0304-3959(03)00138-6. PMID: 12927638.
Article
6. Tawfik VL, Regan MR, Haenggeli C, Lacroix-Fralish ML, Nutile-McMenemy N, Perez N, et al. 2008; Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience. 152:1086–92. DOI: 10.1016/j.neuroscience.2008.01.065. PMID: 18358622. PMCID: PMC2423012.
Article
7. Ellis A, Wieseler J, Favret J, Johnson KW, Rice KC, Maier SF, et al. 2014; Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain. J Pain. 15:407–21. DOI: 10.1016/j.jpain.2013.12.007. PMID: 24412802. PMCID: PMC3972272.
Article
8. Gwak YS, Crown ED, Unabia GC, Hulsebosch CE. 2008; Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat. Pain. 138:410–22. DOI: 10.1016/j.pain.2008.01.021. PMID: 18353556. PMCID: PMC2676790.
Article
9. Zhang J, Wu D, Xie C, Wang H, Wang W, Zhang H, et al. 2013; Tramadol and propentofylline coadministration exerted synergistic effects on rat spinal nerve ligation-induced neuropathic pain. PLoS One. 8:e72943. DOI: 10.1371/journal.pone.0072943. PMID: 24009718. PMCID: PMC3756942.
Article
10. Brennan TJ, Vandermeulen EP, Gebhart GF. 1996; Characterization of a rat model of incisional pain. Pain. 64:493–501. DOI: 10.1016/0304-3959(95)01441-1. PMID: 8783314.
Article
11. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. 2010; Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8:e1000412. DOI: 10.1371/journal.pbio.1000412. PMID: 20613859.
Article
12. Sluka KA, Kalra A, Moore SA. 2001; Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve. 24:37–46. DOI: 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8. PMID: 11150964.
Article
13. Kim TK, Kim YS, Yoon JR, Han IS, Kim JS, Lee CW. 2004; The effect of an intraperitoneal injection of ketamine and ketorolac on mechanical allodynia in rats with spinal nerve ligation. Korean J Anesthesiol. 46:719–23. DOI: 10.4097/kjae.2004.46.6.719.
Article
14. Macrae WA. 2001; Chronic pain after surgery. Br J Anaesth. 87:88–98. DOI: 10.1093/bja/87.1.88. PMID: 11460816.
Article
15. Sweitzer SM, Schubert P, DeLeo JA. 2001; Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther. 297:1210–7. PMID: 11356948.
16. Jung S, Donhauser T, Toyka KV, Hartung HP. 1997; Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats. J Autoimmun. 10:519–29. DOI: 10.1006/jaut.1997.0159. PMID: 9451591.
17. Sommer C, Kress M. 2004; Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 361:184–7. DOI: 10.1016/j.neulet.2003.12.007. PMID: 15135924.
Article
18. Watkins LR, Maier SF, Goehler LE. 1995; Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 63:289–302. DOI: 10.1016/0304-3959(95)00186-7. PMID: 8719529.
Article
19. Colburn RW, DeLeo JA, Rickman AJ, Yeager MP, Kwon P, Hickey WF. 1997; Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol. 79:163–75. DOI: 10.1016/S0165-5728(97)00119-7. PMID: 9394789.
Article
20. Schubert P, Morino T, Miyazaki H, Ogata T, Nakamura Y, Marchini C, et al. 2000; Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann N Y Acad Sci. 903:24–33. DOI: 10.1111/j.1749-6632.2000.tb06346.x. PMID: 10818485.
Article
21. Schubert P, Ogata T, Rudolphi K, Marchini C, McRae A, Ferroni S. 1997; Support of homeostatic glial cell signaling: a novel therapeutic approach by propentofylline. Ann N Y Acad Sci. 826:337–47. DOI: 10.1111/j.1749-6632.1997.tb48484.x. PMID: 9329704. PMCID: PMC7137904.
Article
22. Clark IA. 2007; How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 18:335–43. DOI: 10.1016/j.cytogfr.2007.04.002. PMID: 17493863.
Article
23. Luo G, Hershko DD, Robb BW, Wray CJ, Hasselgren PO. 2003; IL-1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kappa B. Am J Physiol Regul Integr Comp Physiol. 284:R1249–54. DOI: 10.1152/ajpregu.00490.2002. PMID: 12676746.
24. Crassous PA, Denis C, Paris H, Sénard JM. 2007; Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr Top Med Chem. 7:187–94. DOI: 10.2174/156802607779318190. PMID: 17266605.
25. Lavand'homme PM, Eisenach JC. 2003; Perioperative administration of the alpha2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression. Pain. 105:247–54. DOI: 10.1016/S0304-3959(03)00221-5. PMID: 14499442.
26. Schechtmann G, Song Z, Ultenius C, Meyerson BA, Linderoth B. 2008; Cholinergic mechanisms involved in the pain relieving effect of spinal cord stimulation in a model of neuropathy. Pain. 139:136–45. DOI: 10.1016/j.pain.2008.03.023. PMID: 18472215.
Article
27. Jessen Lundorf L, Korvenius Nedergaard H, Møller AM. 2016; Perioperative dexmedetomidine for acute pain after abdominal surgery in adults. Cochrane Database Syst Rev. 2:CD010358. DOI: 10.1002/14651858.CD010358.pub2. PMID: 26889627.
Article
28. Boyer KC, McDonald P, Zoetis T. 2010; A novel formulation of ketorolac tromethamine for intranasal administration: preclinical safety evaluation. Int J Toxicol. 29:467–78. DOI: 10.1177/1091581810374372. PMID: 20884857.
Article
29. Chellman GJ, Lollini LO, Dorr AE, DePass LR. 1994; Comparison of ketorolac tromethamine with other injectable nonsteroidal anti-inflammatory drugs for pain-on-injection and muscle damage in the rat. Hum Exp Toxicol. 13:111–7. DOI: 10.1177/096032719401300209. PMID: 7908807.
Article
30. Malmberg AB, Yaksh TL. 1992; Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther. 263:136–46. DOI: 10.1016/j.pain.2009.08.013. PMID: 1403779.
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr